Compare IHG & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IHG | WST |
|---|---|---|
| Founded | 1777 | 1923 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 20.1B |
| IPO Year | N/A | N/A |
| Metric | IHG | WST |
|---|---|---|
| Price | $134.45 | $280.27 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | N/A | ★ $346.78 |
| AVG Volume (30 Days) | 149.3K | ★ 661.1K |
| Earning Date | 01-01-0001 | 10-23-2025 |
| Dividend Yield | ★ 1.25% | 0.31% |
| EPS Growth | ★ 21.99 | 0.17 |
| EPS | 4.70 | ★ 6.75 |
| Revenue | ★ $5,120,000,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | $6.21 | $6.20 |
| P/E Ratio | ★ $28.68 | $41.65 |
| Revenue Growth | ★ 33.89 | 4.92 |
| 52 Week Low | $94.78 | $187.43 |
| 52 Week High | $137.73 | $348.90 |
| Indicator | IHG | WST |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 55.55 |
| Support Level | $132.36 | $269.08 |
| Resistance Level | $137.73 | $285.54 |
| Average True Range (ATR) | 2.03 | 7.15 |
| MACD | 0.29 | 1.31 |
| Stochastic Oscillator | 73.45 | 83.52 |
InterContinental Hotels Group operates 987,000 rooms across 19 brands addressing the midscale through luxury segments, as of Dec. 31, 2024. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2024, the Americas represented 53% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 27%.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.